PLA полиморфизм гена GP3A — новый прогностический фактор рака почки

1. Аксель Е.М. Заболеваемость злокачественными новообразованиями мочевых и мужских половых органов в России в 2003 г. Онкоурология 2005;(1):6—9.

2. Atkins M.B., Avigan D.E., Bukowski R.M. et al. Innovations and challenges in renal cancer: consensus statement from the first international conference. Clin Cancer Res 2004;10(18 Pt 2):6277S—81S.

3. Linehan W.M., Zbar. B. Focus on kidney cancer. Cancer Cell 2004;6(3):223—8.

4. Atkins М.B., Regan M., McDermott D. Update on the role of interleukin 2 and other cytokines in the treatment of patients with stage IV renal carcinoma. Clin Cancer Res 2004;10(18 Pt 2):6342S—6S.

5. Potter C., Harris A.L. Hypoxia inducible carbonic anhydrase IX, marker of tumor hypoxia, survial pathway and therapy target. Cell Cycle 2004;3:164—7.

6. Bamias A., Chorti M., Deliveliotis C. et al. Prognostic significanсe of CA 125, CD 44 and epithelial membrane antigen in renal cell carcinoma. Urology 2003;62(2):368—73.

7. Kim H.L., Stligson D., Liu X. et al. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. J Urol 2005;173(5):1496—501.

8. Syrigos K.N., Harrington K.J., Pignatelli M. et al. Role of adhesion molecules in bladder cancer: an important part of the jigsaw. Urology 1999;53(2):428—34.

9. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991;22(251):1451—5.

10. Bojesen S.E., Tybjaerg-Hansen A., Nordestgaard B.G. Integrin 3 Leu33Pro homozygosity and risk of cancer. J Natl Cancer Inst 2003;95:1150—7.

11. Серегин А.А. Клиническое значение аллельного распределения гена GP3A при раке предстательной железы. Автореф. дис. … канд. мед наук. М.; 2005.

12. Staehler M., Rohrman K., Haseke N., Stief C.G. Targeted agents for the treatment of advanced renal cell carcinoma. Curr Drug Targets 2005;6(7):835—46.

13. Huber W., Boer J.M., von Heydeberck A. et al. Transcription profiling of renal cell carcinoma. Verh Dtsch Ges Pathol 2002;86:153—64.

14. Wechsel H.W., Petri E., Feil G. et al. Renal cell carcinoma: immunohistological investigation of expression of the integrin alpha v beta 3. Anticancer Res 1999;19(2C):1529—32.